David Geffen School of Medicine, University of California, Los Angeles Los Angeles, California, United States
This program will feature different perspectives on advancing acromegaly treatment in adults with acromegaly following inadequate response to surgery or when surgery is not an option. Speakers will review key clinical challenges, treatment goals, and decision making considerations across treatment naïve and previously treated patients. The session will also highlight clinical trial evidence supporting the role of once daily oral PALSONIFY™ (paltusotine) in achieving biochemical and symptom control.
.jpg)
.jpg)
